CN1081898A - Lingmu bean eye drops - Google Patents
Lingmu bean eye drops Download PDFInfo
- Publication number
- CN1081898A CN1081898A CN 93104973 CN93104973A CN1081898A CN 1081898 A CN1081898 A CN 1081898A CN 93104973 CN93104973 CN 93104973 CN 93104973 A CN93104973 A CN 93104973A CN 1081898 A CN1081898 A CN 1081898A
- Authority
- CN
- China
- Prior art keywords
- wild
- medicine
- pure
- wine
- eye
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000046052 Phaseolus vulgaris Species 0.000 title abstract 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 title abstract 2
- 239000003889 eye drop Substances 0.000 title 1
- 229940012356 eye drops Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract description 15
- 241000305492 Gastrodia Species 0.000 claims abstract description 13
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims abstract description 10
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims abstract description 10
- 241000411851 herbal medicine Species 0.000 claims abstract description 9
- 208000030533 eye disease Diseases 0.000 claims abstract description 8
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 5
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 5
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 5
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 5
- 229940023490 ophthalmic product Drugs 0.000 claims description 11
- 150000002333 glycines Chemical class 0.000 claims description 7
- 238000001556 precipitation Methods 0.000 claims description 4
- 238000011282 treatment Methods 0.000 claims description 4
- 238000007654 immersion Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000003672 processing method Methods 0.000 claims description 3
- 239000003053 toxin Substances 0.000 claims description 3
- 231100000765 toxin Toxicity 0.000 claims description 3
- 239000004576 sand Substances 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 206010003694 Atrophy Diseases 0.000 abstract description 4
- 230000037444 atrophy Effects 0.000 abstract description 4
- 208000002177 Cataract Diseases 0.000 abstract description 3
- 208000031973 Conjunctivitis infective Diseases 0.000 abstract description 3
- 208000010412 Glaucoma Diseases 0.000 abstract description 3
- 208000034700 Vitreous opacities Diseases 0.000 abstract description 3
- 201000001028 acute contagious conjunctivitis Diseases 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 3
- 201000001371 inclusion conjunctivitis Diseases 0.000 abstract description 3
- 206010023332 keratitis Diseases 0.000 abstract description 3
- 208000001491 myopia Diseases 0.000 abstract description 3
- 230000004379 myopia Effects 0.000 abstract description 3
- 201000010041 presbyopia Diseases 0.000 abstract description 3
- 206010044325 trachoma Diseases 0.000 abstract description 3
- 230000009385 viral infection Effects 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 230000002980 postoperative effect Effects 0.000 abstract description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 abstract 2
- 206010011844 Dacryocystitis Diseases 0.000 abstract 1
- 241000287127 Passeridae Species 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 239000003885 eye ointment Substances 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 235000012424 soybean oil Nutrition 0.000 abstract 1
- 239000003549 soybean oil Substances 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
- 210000001508 eye Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 3
- 208000036142 Viral infection Diseases 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 208000022873 Ocular disease Diseases 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention belongs to a traditional Chinese medicine Lingmu bean eye ointment which is processed and prepared by a Chinese herbal medicine formula and used for treating eye diseases. The main formula components of the medicine are as follows: abalone shell, wild cassia, wild chrysanthemum, wild gastrodia tuber, wild chrysanthemum notoginseng, pure bilirubin, pure grain wine and pure high-quality soybean oil, and has unique curative effect on dozens of eye diseases such as presbyopia, myopia, trachoma, dacryocystitis, blurred eye, sparrow blurred eye, keratitis, pinkeye, glaucoma, cataract, fundus atrophy, vitreous opacity virus infection, postoperative recurrence disease caused by trauma, etc., and has very obvious functions of diminishing inflammation, relieving pain and detoxifying.
Description
The invention belongs to a kind of Chinese medicine medicine oil as ophthalmic medicine with Chinese herbal medicine formula processing and fabricating treatment oculopathy.
At present, the people who has a trouble in one's eyesight in the world is many, as: myopia, presbyopia, trachoma, dacryocystisis, fire dim eye, the dim eye of passeris montani saturati, keratitis, pink eye disease, glaucoma, cataract, optical fundus atrophy, vitreous opacity viral infection, wound causes and tens kinds of oculopathy such as postoperative recurrence disease.Though all multi-method treatments are arranged, and curative effect is not remarkable, the recurrence after operation that has, what have can only maintain the statusquo.Make persons suffering from ocular disorders very painful.
The object of the present invention is to provide a kind of: with the Chinese medicine medicine oil as ophthalmic medicine of Chinese herbal medicine formula processing and fabricating.It is China's odd-prescription handed down from one's ancestors, now secretly hands down two over thousands of years.Some insurmountable problems that present treatment oculopathy exists have been solved.
The object of the present invention is achieved like this: oil as ophthalmic medicine mainly fill a prescription composition by: Concha Haliotidis 8g, wild cassia sead 8g, wild chrysanthemum 10g, Wild gastrodia 9g, wild chrysanthemum panax notoginseng 10g, pure bilixanthin 10g, pure 80 degree grain wine 1500g, pure high-quality Oleum Glycines 500g processing is formulated.Its processing method is the above-mentioned wild Chinese patent medicine of gathering, Chinese herbal medicine is smashed to pieces with pot and is fried, toxin with Wild gastrodia extract again, with 80 degree pure grain steeping in wine bubble Wild gastrodias, and then, soak after 75 days with steeping in wine bubble said herbal medicine, Chinese patent medicine that the immersion Wild gastrodia is separated, the sedimentary method of reuse is filtered three times, wine is separated, and the pure high-quality Oleum Glycines of reuse soaked after 110 days, filtered five times with sedimentary method.Just become oil as ophthalmic medicine.
Oil as ophthalmic medicine of the present invention can be treated presbyopia, myopia, trachoma, dacryocystisis, fire dim eye, keratitis, pink eye disease, glaucoma, cataract, optical fundus atrophy, vitreous opacity viral infection, wound causes and tens kinds of oculopathy such as recurrence after operation disease, and externally applied anti-inflammation, pain relieving and Detoxication are very remarkable.As a patient because of puerperal exposure to wind optical fundus atrophy 29 years, the recessed thing that do not see of eyeball, a slice BAIMANG was at the moment dripped medicine three months, eyes are seen light again, eyeball is heaved.This medicine is surveyed and is claimed that China one is exhausted, the jinx of expression in the eyes, oculopathy, and title among the people is tackled all problems at once, and is the national treasure of Chinese medical.
Be most preferred embodiment of the present invention below: oil as ophthalmic medicine mainly fill a prescription composition by: Concha Haliotidis 8g, wild cassia sead 8g, wild chrysanthemum 10g, Wild gastrodia 9g, wild chrysanthemum panax notoginseng 10g, pure bilixanthin 10g, pure 80 degree grain wine 1500g, pure high-quality Oleum Glycines 500g processing are formulated.Its processing method is that above-mentioned wild Chinese patent medicine, the Chinese herbal medicine gathered are smashed to pieces, fry with pot, toxin with Wild gastrodia extract again, remove to soak the Wild gastrodia of carrying behind the poison with 80 degree pure grain wine 1500g, and then the Concha Haliotidis 8g of the steeping in wine of separating with immersion Wild gastrodia bubble after smashing to pieces and frying, wild cassia sead 8g, wild chrysanthemum 10g, wild chrysanthemum Radix Notoginseng 10g, pure bilixanthin 10g.Soak after 75 days, filter three times with precipitation mode, wine is separated, the pure high-quality Oleum Glycines of reuse 500g(does not have the Oleum Glycines that small holes caused by worms do not have the Semen sojae atricolor extrusion process of any impurity), soak after 110 days, filter five times with precipitation mode, just become oil as ophthalmic medicine.
Claims (2)
1, the invention belongs to a kind of Chinese medicine medicine oil as ophthalmic medicine, it is characterized in that with Chinese herbal medicine formula processing and fabricating treatment oculopathy: it mainly fill a prescription composition by: Concha Haliotidis 8g, wild cassia sead 8g, wild chrysanthemum 10g, Wild gastrodia 9g, wild chrysanthemum panax notoginseng 10g, pure bilixanthin 10g, pure 80 degree grain wine 1500g, pure high-quality Oleum Glycines 500g, processing are formulated.
2, also be according to its feature of the described oil as ophthalmic medicine of claim (1): its processing method is that above-mentioned wild Chinese patent medicine, the Chinese herbal medicine gathered are smashed to pieces with pot sand, toxin with Wild gastrodia extract again, with 80 degree pure grain steeping in wine bubble Wild gastrodias, and then the steeping in wine of separating with immersion Wild gastrodia bubble said herbal medicine, Chinese patent medicine, soak after 75 days, the reuse precipitation mode is filtered three times, wine is separated, the pure high-quality Oleum Glycines of reuse soaked after 110 days, filter five times with precipitation mode, just become oil as ophthalmic medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93104973 CN1081898A (en) | 1993-04-24 | 1993-04-24 | Lingmu bean eye drops |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93104973 CN1081898A (en) | 1993-04-24 | 1993-04-24 | Lingmu bean eye drops |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1081898A true CN1081898A (en) | 1994-02-16 |
Family
ID=4985490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 93104973 Pending CN1081898A (en) | 1993-04-24 | 1993-04-24 | Lingmu bean eye drops |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1081898A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1056756C (en) * | 1994-12-16 | 2000-09-27 | 赵志强 | Vision recovery capsule |
| CN1063332C (en) * | 1995-03-10 | 2001-03-21 | 宫建平 | Medicinal composition for curing eye injury |
| CN1064848C (en) * | 1997-04-25 | 2001-04-25 | 何众 | Chinese herbal medicine preparation for glaucoma |
| CN104997954A (en) * | 2014-04-20 | 2015-10-28 | 匡晔 | Eye medicinal oil and preparation method thereof |
| CN111346131A (en) * | 2018-12-24 | 2020-06-30 | 智德明创生物科技(北京)有限公司 | Traditional Chinese medicine eye patch for preventing and treating juvenile myopia and preparation method thereof |
-
1993
- 1993-04-24 CN CN 93104973 patent/CN1081898A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1056756C (en) * | 1994-12-16 | 2000-09-27 | 赵志强 | Vision recovery capsule |
| CN1063332C (en) * | 1995-03-10 | 2001-03-21 | 宫建平 | Medicinal composition for curing eye injury |
| CN1064848C (en) * | 1997-04-25 | 2001-04-25 | 何众 | Chinese herbal medicine preparation for glaucoma |
| CN104997954A (en) * | 2014-04-20 | 2015-10-28 | 匡晔 | Eye medicinal oil and preparation method thereof |
| CN111346131A (en) * | 2018-12-24 | 2020-06-30 | 智德明创生物科技(北京)有限公司 | Traditional Chinese medicine eye patch for preventing and treating juvenile myopia and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102631558B (en) | Medicament for treating eye disease and preparation method of medicament | |
| CN106491968A (en) | A kind of improving eyesight solid beverage and preparation method thereof | |
| CN109430856A (en) | A kind of eye-protecting improves the Ricipe for health care food and preparation method thereof of visual fatigue | |
| CN1081898A (en) | Lingmu bean eye drops | |
| EP3799567B1 (en) | Eye drops comprising citric acid as the sole active ingredient | |
| CN107441159A (en) | A kind of alleviation visual fatigue, the Chinese medicine composition of mist, its eye sticker and preparation method | |
| CN110859895A (en) | Eye ointment and preparation method thereof | |
| CN113413415B (en) | Lanosterol eye drops and preparation method thereof | |
| CN101468114A (en) | Product for protecting vision and method for preparing the same | |
| CN101390997B (en) | Jianmu capsule and preparation method thereof | |
| CN1081899A (en) | Guangling ointment | |
| CN109581693A (en) | A kind of plant crystal room temperature gasification glasses preventing near-sighted cataract | |
| CN115089633B (en) | Composition for preventing and treating myopia, eye mask and preparation method | |
| CN107684565A (en) | A kind of medicine for treating blood-shoot-eye illness and preparation method thereof | |
| CN209070254U (en) | A kind of plant crystal room temperature gasification glasses preventing near-sighted cataract | |
| CN1108130A (en) | Herbal medicine prepn. for treating cataract and its prepn. method | |
| CN107050376A (en) | A kind of Chinese medicine composition for treating and preventing ophthalmology disease | |
| CN106177041A (en) | A kind of Chinese medicine of improving acuity of vision and removing nebula and preparation method thereof | |
| CN1086137C (en) | Chinese patent medicine for curing senile cataract | |
| CN105288168A (en) | Pharmaceutical composition for treating keratitis caused by liver and gall with exuberant fire and preparation method thereof | |
| CN111544517A (en) | Traditional Chinese medicine eye cream and preparation method thereof | |
| CN115887561A (en) | Eye ointment with function of treating eye diseases and production process thereof | |
| CN111035676A (en) | Organic selenium eye drops for preventing and relieving eye diseases of old people and preparation method thereof | |
| CN114288347A (en) | Medicine and food composition for benefiting eyesight and improving eyesight and preparation method and application method thereof | |
| CN105148118B (en) | A kind of Chinese medicine composition medicament and preparation method thereof for treating xerophthalmia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |